Company news
EMV Capital PLC news in 2017
EMV Capital PLC's news releases, calls and decks from 2017, newest first.
Wanda Awarded Two Patents
December 12, 2017
ProAxsis: Sales Update
November 21, 2017
Vortex Announces First Commercial VTX-1 Sale
November 7, 2017
HRS Expands Use of Wanda to All Patients
November 3, 2017
Glycotest Adds Allowed Chinese Patent to Portfolio
November 2, 2017
Vortex Announces Liquid Biopsy Study in NPJ
November 1, 2017
ProAxsis Showcases ProteaseTag® Research at NACFC
October 30, 2017
ProAxsis Partnership - US National Jewish Health
October 27, 2017
Directorate Change
October 25, 2017
Glycotest Granted Japanese Patent
October 5, 2017
Wanda Awarded US Patent
October 2, 2017
2017 Interim Results
September 28, 2017
ProAxsis appoints Diagenics Limited as Distributor
September 14, 2017
ProAxsis Signs Partnership: Biotechnology Company
September 11, 2017
ProAxsis is awarded a European CE Mark
September 4, 2017
ProAxsis awarded a Significant Innovate UK Grant
July 24, 2017
PDS Announces Clinical Collaboration with Merck
July 10, 2017
Glycotest Strengthens Intellectual Property Reach
July 7, 2017
Glycotest Update
June 26, 2017
Holdings in Company
June 16, 2017
Results of Placing and Subscription
May 26, 2017
Vortex Initiates Clinical Research Studies
May 24, 2017
ProAxsis announces additional IP
May 10, 2017
ProAxsis Presents New Data at Major US Conference
May 5, 2017
BTG purchases Wanda's shares in Oncoverse
April 24, 2017
Full Year Results for the year ended 31 Dec 2016
April 3, 2017
Vortex Biosciences Announces Publications
March 31, 2017
Notice of Preliminary Results
March 27, 2017
Vortex Biosciences Launches VTX-1 Liquid Biopsy
February 22, 2017
Vortex Biosciences' CSO Wins SLAS Innovation Award
February 15, 2017
Vortex Biosciences' CSO Finalist for SLAS Award
February 9, 2017